{"id":2478,"date":"2016-01-25T23:27:50","date_gmt":"2016-01-25T23:27:50","guid":{"rendered":"https:\/\/latam.patiadiabetes.com\/patia\/comite-cientifico\/michel-marre\/?lang=en"},"modified":"2020-12-07T18:13:47","modified_gmt":"2020-12-07T16:13:47","slug":"michel-marre","status":"publish","type":"page","link":"https:\/\/latam.patiadiabetes.com\/en\/patia\/scientific-committee\/michel-marre\/","title":{"rendered":"Michel Marre"},"content":{"rendered":"<div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-1 hundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"background-color: rgba(255,255,255,0);background-position: center center;background-repeat: no-repeat;padding-top:0px;padding-right:0px;padding-bottom:0px;padding-left:0px;margin-bottom: 0px;margin-top: 0px;border-width: 0px 0px 0px 0px;border-color:#eae9e9;border-style:solid;\" ><div class=\"fusion-builder-row fusion-row\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-0 fusion_builder_column_1_1 1_1 fusion-one-full fusion-column-first fusion-column-last fusion-column-no-min-height\" style=\"margin-top:0px;margin-bottom:0px;\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 0px 0px 0px 0px;\"><style type=\"text\/css\"><\/style><div class=\"fusion-title title fusion-title-1 fusion-sep-none fusion-title-text fusion-title-size-one\" style=\"margin-top:0px;margin-right:0px;margin-bottom:31px;margin-left:0px;\"><h1 class=\"title-heading-left fusion-responsive-typography-calculated\" style=\"margin:0;--fontSize:45;line-height:1.24;\">Michel Marre<\/h1><\/div><div class=\"fusion-text fusion-text-1\"><p><img decoding=\"async\" class=\"lazyload wp-image-1726 size-full alignleft\" src=\"https:\/\/latam.patiadiabetes.com\/wp-content\/uploads\/2016\/01\/michel-marre.png\" data-orig-src=\"https:\/\/latam.patiadiabetes.com\/wp-content\/uploads\/2016\/01\/michel-marre.png\" alt=\"\" width=\"155\" height=\"155\" srcset=\"data:image\/svg+xml,%3Csvg%20xmlns%3D%27http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%27%20width%3D%27155%27%20height%3D%27155%27%20viewBox%3D%270%200%20155%20155%27%3E%3Crect%20width%3D%27155%27%20height%3D%27155%27%20fill-opacity%3D%220%22%2F%3E%3C%2Fsvg%3E\" data-srcset=\"https:\/\/latam.patiadiabetes.com\/wp-content\/uploads\/2016\/01\/michel-marre-66x66.png 66w, https:\/\/latam.patiadiabetes.com\/wp-content\/uploads\/2016\/01\/michel-marre-150x150.png 150w, https:\/\/latam.patiadiabetes.com\/wp-content\/uploads\/2016\/01\/michel-marre.png 155w\" data-sizes=\"auto\" data-orig-sizes=\"(max-width: 155px) 100vw, 155px\" \/><\/p>\n<h3>Dr. Michel Marre<\/h3>\n<p>Hospital Bichat-Claude Bernard<br \/>\n<span style=\"font-weight: 400;\">Public Hospital Network of Paris<\/span><\/p>\n<\/div><div class=\"fusion-sep-clear\"><\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"margin-left: auto;margin-right: auto;margin-top:10px;margin-bottom:10px;width:100%;\"><\/div><div class=\"fusion-sep-clear\"><\/div><div class=\"fusion-text fusion-text-2\"><h3>Biography<\/h3>\n<p><span style=\"font-weight: 400;\">President of the FFRD, Head of the Diabetology, Endocrinology and Nutrition Department of Bichat-Claude Bernard Hospital Michel Marre is President of the Francophone Foundation for Diabetes Research and also Head of the Diabetology, Endocrinology and Nutrition Department of Bichat-Claude Bernard Hospital Group of the Public Hospital Network of Paris. He is Professor of Endocrinology, Diabetes and Metabolic Diseases at the University of Denis Diderot-Paris 7. <\/span><\/p>\n<h3>Diabetes<\/h3>\n<p><span style=\"font-weight: 400;\">Until the end of 2013, he also managed the INSERM U695 unit, which is dedicated to the genetic determinants of type 2 diabetes and its vascular complications. Since the beginning of his internship in 1975, he has conducted translational activities between the management of individuals with diabetes and the clinical and basic research. <\/span><span style=\"font-weight: 400;\">His primary interest is the renal complications of diabetes mellitus. <\/span><\/p>\n<p><span style=\"font-weight: 400;\">Michel Marre was President of the Scientific Council and then President of the Francophone Society of Diabetes (SFD, formerly ALFEDIAM), and with Professor Bernard Bauduceau he created the Francophone Foundation for Diabetes Research. <\/span><\/p>\n<h3>Publications<\/h3>\n<p><span style=\"font-weight: 400;\">He is the author or co-author of more than 350 scientific articles. <\/span><\/p>\n<p><span style=\"font-weight: 400;\">Several publications \u2013 Ronan Roussel, Florence Travert, Blandine Pasquet, Peter F. Wilson, Sidney C. Smith Jr, Shinya Goto, Philippe Ravaud, Michel Marre, AviPorath, MD, Deepak L. Bhatt, MD, Ph. Gabriel Steg, for the REACHinvestigators Metformin Use and Mortality Among Diabetic Patients with Established Atherothrombosis, Arch Intern Med, Nov. 22, 2010. \u2013 Zoungas S, Patel A, Chalmers J, de Galan BE, Li Q, Billot L, Woodward M, Ninomiya T, Neal B, MacMahon S, Grobbee DE, Kengne AP, Marre M, Heller S; ADVANCE Collaborative Group. Severe hypoglycemia and risks of vascular events and death. N Engl J Med. 2010 Oct 7; 363(15):1410=8. \u2013 Khalil CA, Travert F, Fetita S, Rouzet F, Porcher R, Riveline JP, Hadjadj S, Larger E, Roussel R, Vexiau P, Le Guludec D, Gautier JF, Marre M. Fetal exposure to maternal type 1 diabetes is associated with renal dysfunction at adult age. Diabetes. 2010 Oct; 59(10):2631-6. Epub 2010 Jul 9.<\/span><\/p>\n<\/div><div class=\"fusion-clearfix\"><\/div><\/div><\/div><\/div><style type=\"text\/css\">.fusion-fullwidth.fusion-builder-row-1 { overflow:visible; }<\/style><\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":5,"featured_media":0,"parent":2472,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"side-navigation.php","meta":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v19.14 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Michel Marre - Comit\u00e9 cient\u00edfico Diabetes Prevent<\/title>\n<meta name=\"description\" content=\"El programa para conocer la predisposici\u00f3n gen\u00e9tica a padecer diabetes tipo 2 y de prevenci\u00f3n de la diabetes DIABETESprevent est\u00e1 avalado por el Dr. Michel Marre, presidente de la Fundaci\u00f3n para la Investigaci\u00f3n de la Diabetes de habla francesa y jefe del Servicio de Endocrinolog\u00eda,Diabetes y Nutrici\u00f3n grupo del hospital Bichat-Claude Bernard de los hospitales p\u00fablicos de Par\u00eds. Compagina su actividad profesional entre la atenci\u00f3n cl\u00ednica de personas con diabetes y la investigaci\u00f3n experimental y cl\u00ednica. Su inter\u00e9s principal est\u00e1 en complicaciones renales de la diabetes mellitus.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/latam.patiadiabetes.com\/en\/patia\/scientific-committee\/michel-marre\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Michel Marre - Comit\u00e9 cient\u00edfico Diabetes Prevent\" \/>\n<meta property=\"og:description\" content=\"El programa para conocer la predisposici\u00f3n gen\u00e9tica a padecer diabetes tipo 2 y de prevenci\u00f3n de la diabetes DIABETESprevent est\u00e1 avalado por el Dr. Michel Marre, presidente de la Fundaci\u00f3n para la Investigaci\u00f3n de la Diabetes de habla francesa y jefe del Servicio de Endocrinolog\u00eda,Diabetes y Nutrici\u00f3n grupo del hospital Bichat-Claude Bernard de los hospitales p\u00fablicos de Par\u00eds. Compagina su actividad profesional entre la atenci\u00f3n cl\u00ednica de personas con diabetes y la investigaci\u00f3n experimental y cl\u00ednica. Su inter\u00e9s principal est\u00e1 en complicaciones renales de la diabetes mellitus.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/latam.patiadiabetes.com\/en\/patia\/scientific-committee\/michel-marre\/\" \/>\n<meta property=\"og:site_name\" content=\"PATIA Diabetes\" \/>\n<meta property=\"article:modified_time\" content=\"2020-12-07T16:13:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/latam.patiadiabetes.com\/wp-content\/uploads\/2016\/01\/michel-marre.png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/latam.patiadiabetes.com\/en\/patia\/scientific-committee\/michel-marre\/\",\"url\":\"https:\/\/latam.patiadiabetes.com\/en\/patia\/scientific-committee\/michel-marre\/\",\"name\":\"Michel Marre - Comit\u00e9 cient\u00edfico Diabetes Prevent\",\"isPartOf\":{\"@id\":\"https:\/\/latam.patiadiabetes.com\/#website\"},\"datePublished\":\"2016-01-25T23:27:50+00:00\",\"dateModified\":\"2020-12-07T16:13:47+00:00\",\"description\":\"El programa para conocer la predisposici\u00f3n gen\u00e9tica a padecer diabetes tipo 2 y de prevenci\u00f3n de la diabetes DIABETESprevent est\u00e1 avalado por el Dr. Michel Marre, presidente de la Fundaci\u00f3n para la Investigaci\u00f3n de la Diabetes de habla francesa y jefe del Servicio de Endocrinolog\u00eda,Diabetes y Nutrici\u00f3n grupo del hospital Bichat-Claude Bernard de los hospitales p\u00fablicos de Par\u00eds. Compagina su actividad profesional entre la atenci\u00f3n cl\u00ednica de personas con diabetes y la investigaci\u00f3n experimental y cl\u00ednica. Su inter\u00e9s principal est\u00e1 en complicaciones renales de la diabetes mellitus.\",\"breadcrumb\":{\"@id\":\"https:\/\/latam.patiadiabetes.com\/en\/patia\/scientific-committee\/michel-marre\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/latam.patiadiabetes.com\/en\/patia\/scientific-committee\/michel-marre\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/latam.patiadiabetes.com\/en\/patia\/scientific-committee\/michel-marre\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Patia\",\"item\":\"https:\/\/latam.patiadiabetes.com\/en\/patia\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Scientific committee\",\"item\":\"https:\/\/latam.patiadiabetes.com\/en\/patia\/scientific-committee\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Michel Marre\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/latam.patiadiabetes.com\/#website\",\"url\":\"https:\/\/latam.patiadiabetes.com\/\",\"name\":\"PATIA Diabetes\",\"description\":\"T\u00fa puedes prevenir la diabetes tipo 2\",\"publisher\":{\"@id\":\"https:\/\/latam.patiadiabetes.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/latam.patiadiabetes.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/latam.patiadiabetes.com\/#organization\",\"name\":\"Patia\",\"url\":\"https:\/\/latam.patiadiabetes.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/latam.patiadiabetes.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.patiadiabetes.com\/wp-content\/uploads\/2016\/01\/PATIA-logo.png\",\"contentUrl\":\"https:\/\/www.patiadiabetes.com\/wp-content\/uploads\/2016\/01\/PATIA-logo.png\",\"width\":150,\"height\":80,\"caption\":\"Patia\"},\"image\":{\"@id\":\"https:\/\/latam.patiadiabetes.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Michel Marre - Comit\u00e9 cient\u00edfico Diabetes Prevent","description":"El programa para conocer la predisposici\u00f3n gen\u00e9tica a padecer diabetes tipo 2 y de prevenci\u00f3n de la diabetes DIABETESprevent est\u00e1 avalado por el Dr. Michel Marre, presidente de la Fundaci\u00f3n para la Investigaci\u00f3n de la Diabetes de habla francesa y jefe del Servicio de Endocrinolog\u00eda,Diabetes y Nutrici\u00f3n grupo del hospital Bichat-Claude Bernard de los hospitales p\u00fablicos de Par\u00eds. Compagina su actividad profesional entre la atenci\u00f3n cl\u00ednica de personas con diabetes y la investigaci\u00f3n experimental y cl\u00ednica. Su inter\u00e9s principal est\u00e1 en complicaciones renales de la diabetes mellitus.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/latam.patiadiabetes.com\/en\/patia\/scientific-committee\/michel-marre\/","og_locale":"en_GB","og_type":"article","og_title":"Michel Marre - Comit\u00e9 cient\u00edfico Diabetes Prevent","og_description":"El programa para conocer la predisposici\u00f3n gen\u00e9tica a padecer diabetes tipo 2 y de prevenci\u00f3n de la diabetes DIABETESprevent est\u00e1 avalado por el Dr. Michel Marre, presidente de la Fundaci\u00f3n para la Investigaci\u00f3n de la Diabetes de habla francesa y jefe del Servicio de Endocrinolog\u00eda,Diabetes y Nutrici\u00f3n grupo del hospital Bichat-Claude Bernard de los hospitales p\u00fablicos de Par\u00eds. Compagina su actividad profesional entre la atenci\u00f3n cl\u00ednica de personas con diabetes y la investigaci\u00f3n experimental y cl\u00ednica. Su inter\u00e9s principal est\u00e1 en complicaciones renales de la diabetes mellitus.","og_url":"https:\/\/latam.patiadiabetes.com\/en\/patia\/scientific-committee\/michel-marre\/","og_site_name":"PATIA Diabetes","article_modified_time":"2020-12-07T16:13:47+00:00","og_image":[{"url":"https:\/\/latam.patiadiabetes.com\/wp-content\/uploads\/2016\/01\/michel-marre.png"}],"twitter_card":"summary_large_image","twitter_misc":{"Estimated reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/latam.patiadiabetes.com\/en\/patia\/scientific-committee\/michel-marre\/","url":"https:\/\/latam.patiadiabetes.com\/en\/patia\/scientific-committee\/michel-marre\/","name":"Michel Marre - Comit\u00e9 cient\u00edfico Diabetes Prevent","isPartOf":{"@id":"https:\/\/latam.patiadiabetes.com\/#website"},"datePublished":"2016-01-25T23:27:50+00:00","dateModified":"2020-12-07T16:13:47+00:00","description":"El programa para conocer la predisposici\u00f3n gen\u00e9tica a padecer diabetes tipo 2 y de prevenci\u00f3n de la diabetes DIABETESprevent est\u00e1 avalado por el Dr. Michel Marre, presidente de la Fundaci\u00f3n para la Investigaci\u00f3n de la Diabetes de habla francesa y jefe del Servicio de Endocrinolog\u00eda,Diabetes y Nutrici\u00f3n grupo del hospital Bichat-Claude Bernard de los hospitales p\u00fablicos de Par\u00eds. Compagina su actividad profesional entre la atenci\u00f3n cl\u00ednica de personas con diabetes y la investigaci\u00f3n experimental y cl\u00ednica. Su inter\u00e9s principal est\u00e1 en complicaciones renales de la diabetes mellitus.","breadcrumb":{"@id":"https:\/\/latam.patiadiabetes.com\/en\/patia\/scientific-committee\/michel-marre\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/latam.patiadiabetes.com\/en\/patia\/scientific-committee\/michel-marre\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/latam.patiadiabetes.com\/en\/patia\/scientific-committee\/michel-marre\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Patia","item":"https:\/\/latam.patiadiabetes.com\/en\/patia\/"},{"@type":"ListItem","position":2,"name":"Scientific committee","item":"https:\/\/latam.patiadiabetes.com\/en\/patia\/scientific-committee\/"},{"@type":"ListItem","position":3,"name":"Michel Marre"}]},{"@type":"WebSite","@id":"https:\/\/latam.patiadiabetes.com\/#website","url":"https:\/\/latam.patiadiabetes.com\/","name":"PATIA Diabetes","description":"T\u00fa puedes prevenir la diabetes tipo 2","publisher":{"@id":"https:\/\/latam.patiadiabetes.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/latam.patiadiabetes.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/latam.patiadiabetes.com\/#organization","name":"Patia","url":"https:\/\/latam.patiadiabetes.com\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/latam.patiadiabetes.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.patiadiabetes.com\/wp-content\/uploads\/2016\/01\/PATIA-logo.png","contentUrl":"https:\/\/www.patiadiabetes.com\/wp-content\/uploads\/2016\/01\/PATIA-logo.png","width":150,"height":80,"caption":"Patia"},"image":{"@id":"https:\/\/latam.patiadiabetes.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/latam.patiadiabetes.com\/en\/wp-json\/wp\/v2\/pages\/2478"}],"collection":[{"href":"https:\/\/latam.patiadiabetes.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/latam.patiadiabetes.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/latam.patiadiabetes.com\/en\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/latam.patiadiabetes.com\/en\/wp-json\/wp\/v2\/comments?post=2478"}],"version-history":[{"count":0,"href":"https:\/\/latam.patiadiabetes.com\/en\/wp-json\/wp\/v2\/pages\/2478\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/latam.patiadiabetes.com\/en\/wp-json\/wp\/v2\/pages\/2472"}],"wp:attachment":[{"href":"https:\/\/latam.patiadiabetes.com\/en\/wp-json\/wp\/v2\/media?parent=2478"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}